ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/Pharmaceutical Intermediate/Pal-Glu(OSu)-OH
C25H42N2O7
482.6 g/mol
Pharmaceutical Intermediate

Pal-Glu(OSu)-OH

CAS294855-91-7
Category
Pharmaceutical Intermediate
Compound Class
Peptide
Primary Use
Pharmaceutical Intermediate

Pal-Glu(OSu)-OH is a chemical compound used as an intermediate in the manufacturing of liraglutide, a pharmaceutical agent. It features a palmitoyl chain linked to a glutamic acid residue activated with an N-hydroxysuccinimide ester group.

Pharmaceutical intermediate for liraglutide synthesisResearch compound for peptide conjugation studies

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing Pal-Glu(OSu)-OH?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

SimilarStructure SimilarSimilarity 0.81

Pal-Glu(OSu)-OMe

CAS294855-90-6

pharmaceutical intermediate

SimilarStructure SimilarSimilarity 0.75

1-tert-Butyl 5-(2,5-dioxopyrrolidin-1-yl) N-hexadecanoyl-L-glutamate

CAS204521-63-1

research compound

ReferenceSame Category

Ethyl 2-isocyanatoacetate

CAS2949-22-6

pharmaceutical intermediate

ReferenceSame Category

5-Propyl-2-thiouracil

CAS2954-52-1

pharmaceutical intermediate

ReferenceSame Category

Epolamine

CAS2955-88-6

pharmaceutical intermediate

ReferenceSame Category

2-amino-2',5-dichlorobenzophenone

CAS2958-36-3

pharmaceutical intermediate

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Read more
Identifiers
IUPAC Name

(2S)-5-(2,5-dioxopyrrolidin-1-yl)oxy-2-(hexadecanoylamino)-5-oxopentanoic acid

InChIKey

KLBZDGJNRTVIAJ-FQEVSTJZSA-N

SMILES

CCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)ON1C(=O)CCC1=O)C(=O)O

Synonyms (4)
  • Liraglutide Impurity 59
  • Pal-Glu(OSu)-OH

Sourcing Pal-Glu(OSu)-OH?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→